https://www.selleckchem.com/products/amg-232.html
Novel stimulation methods, such as transcranial ultrasound stimulation, await rigorous study in chronic pain. While tDCS is approved for treatment of fibromyalgia in Canada and the European Union, no NIBS method is currently approved for chronic pain in the United States. Increasing sample sizes in randomized clinical trials (RCTs) seems the most efficient way to increase confidence in initial promising results. Trends at funding agencies reveal increased interest and support for NIBS such as recent Requests for Application from the Nat
Like
Comment
Share
